JAK inhibition: The key to treating myeloproliferative neoplasm?

Raoul Tibes, James M. Bogenberger, Ruben A. Mesa

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)583-585
Number of pages3
JournalExpert Review of Hematology
Volume5
Issue number6
DOIs
StatePublished - Dec 1 2012

Keywords

  • JAK
  • myeloproliferative neoplasm
  • quality of life
  • symptom improvement
  • therapy

ASJC Scopus subject areas

  • Hematology

Cite this